Xiang Liu Xueling Zhu Xiaotang Zhou Yirui Xie Dairong Xiang Zhikai Wan Ying Huang Biao Zhu
10.3389/fimmu.2022.1012643
Front Immunol
2022 Oct 3;13:1012643.
acquired immune deficiency syndrome cytokines hemophagocytic lymphohistiocytosis inflammation ruxolitinib therapeutics
CC BY
https://pubmed.ncbi.nlm.nih.gov/36263041/
Acquired Immunodeficiency Syndrome HIV Infections / complications HIV Infections / drug therapy Lymphohistiocytosis, Hemophagocytic / diagnosis Lymphohistiocytosis, Hemophagocytic / drug therapy Lymphohistiocytosis, Hemophagocytic / etiology
Acquired Immunodeficiency Syndrome HIV Infections / complications HIV Infections / drug therapy Lymphohistiocytosis, Hemophagocytic / diagnosis Lymphohistiocytosis, Hemophagocytic / drug therapy Lymphohistiocytosis, Hemophagocytic / etiology Case Reports Research Support, Non-U.S. Gov't Cytokines / metabolism Cytotoxins / therapeutic use Ferritins Humans Male Middle Aged ruxolitinib Cytokines Ferritins Cytotoxins
PMC9573961
36263041
Case report: Ruxolitinib as first-line therapy for secondary hemophagocytic lymphohistiocytosis in patients with AIDS
2022